Saakshi Medtech IPO

Saakshi Medtech Limited

₹1,10,400 /1200 sharesMinimum Investment

Saakshi Medtech IPO Details

Bidding DatesMin. InvestmentLot SizePrice Range
25 Sep ‘23 - 27 Sep ‘23₹1,10,4001,200₹92 - ₹97
Issue SizeIPO Doc
45.16Cr
RHP PDF

About Saakshi Medtech

Incorporated in 2009, Saakshi Medtech is a diversified company engaged in various manufacturing activities. They produce electrical control panels and cabinets used in elevators, air compressors, renewable energy, oil & gas exploration, and electric vehicle charging stations. They manufacture medical X-ray systems for the healthcare industry, offer fabrication services for locomotives, operate a wire harness division for internal electrical control panel needs, and supply the air compressor industry. They have experience in product prototype design, development, functional testing, validation, and verification. With its in-house engineering and design capabilities, Saakshi Medtech provides diverse products and solutions across these categories. Their comprehensive solutions encompass design, process engineering, and manufacturing, including fabrication, assembly, and testing. ;
Founded in
2009
Managing director
Mr. Aniket Vijay Latkar
Parent organisation
Saakshi Medtech Limited

Strengths & Financials of Saakshi Medtech

Strengths
Risks
Since 2018, the company has been certified as a manufacturer of medical diagnostic X-ray equipment by AERB. They also obtained a license to manufacture medical devices for testing from The Central Drugs Standard Control Organisation (CDSCO).
The company's testing lab is now NABL-certified for medical diagnostic X-ray equipment testing.
The company has garnered certificates for its fabrication work in compliance with EN Standards and is recognized as a welding workshop that meets the standard requirements.
Their electrical control panels have CE certification, ensuring product quality and safety. For international export orders of medical X-ray systems, they conduct tests in accordance with IEC standards, facilitating distribution and use in multiple countries.
The company's revenue from operations increased at a CAGR of 42.90% from Rs. 5,977.39 lakhs in 2021 to Rs. 12,205.82 lakhs in 2023. They have also seen profit growth, rising from Rs. 220.08 lakhs in 2021 to Rs. 1,238.30 lakhs in 2023.

Saakshi Medtech Financials

*All values are in Rs. Cr
No Graph Data To Display

Application Details of Saakshi Medtech IPO

Apply asPrice bandApply upto
Regular92 - 97₹2 Lakh
High Networth Individual92 - 97₹2 - 5 Lakh
For Saakshi Medtech IPO, eligible investors can apply as Regular.
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 5.6.2
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ

ABOUT GROWW